Allergan Cleared Of Misconduct At USPTO In Juvederm Spat
Allergan can escape allegations that it improperly obtained its patents in a lawsuit against a competitor over its injectable dermal filler Juvederm, a Delaware federal court ruled Friday....To view the full article, register now.
Already a subscriber? Click here to view full article